HomeInsightsPE

Alpa Laboratories Ltd PE Ratio

Alpa Laboratories Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

2.0 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Alpa Laboratories Ltd

NSE: ALPA

PE

11.4

Last updated on: Nov 24, 2024

Key Highlights

  • The P/E Ratio of Alpa Laboratories Ltd is 11.4 as of 24 Nov 12:10 PM .
  • The P/E Ratio of Alpa Laboratories Ltd changed from 55.2 on March 2019 to 10.5 on March 2024 . This represents a CAGR of -24.16% over 6 years.
  • The Latest Trading Price of Alpa Laboratories Ltd is ₹ 113.3 as of 22 Nov 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.7. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Alpa Laboratories Ltd

No data available

Company Fundamentals for Alpa Laboratories Ltd

No data available

Image

Alpa Laboratories Ltd

NSE: ALPA

Share Price

₹ 113.3

2.25 (2.03%)

stock direction

Last updated on: Nov 22, 2024

Market Price of Alpa Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Alpa Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024113.3
21 Nov 2024111.05
19 Nov 2024114.95
18 Nov 2024113.4
14 Nov 2024108.25
13 Nov 2024112
12 Nov 2024110.25
11 Nov 2024108.9
08 Nov 2024113
07 Nov 2024112.1

SWOT Analysis Of Alpa Laboratories Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Alpa Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Alpa Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Alpa Laboratories Ltd11238
Sun Pharmaceuticals Industries Ltd384,31,352
Divis Laboratories Ltd861,59,265
Cipla Ltd261,20,033
Torrent Pharmaceuticals Ltd611,07,301
Mankind Pharma Ltd481,02,231

Key Valuation Metric of Alpa Laboratories Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Alpa Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Alpa Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Alpa Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Alpa Laboratories Ltd

No data available

* All values are in crore

Historical Dividend Payout of Alpa Laboratories Ltd

No data available

* All values are in %

About Alpa Laboratories Ltd

  • M/s Alpa Laboratories, formed in 1967, was incorporated as Private Limited Company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations.
  • In 1998, the Company was converted into a Public Limited Company with effect from September 3, 1998 with the name of 'Alpa Laboratories Limited'.
  • The facility has dedicated manufacturing areas for different Finished Dosage Forms (FDFs) including liquid injections, dry injections, tablets, capsules, eye drops, ear drops, ointments, creams and gels. In 1997, the company has initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh.
  • The unit commenced commercial production in the year 1999 of all types of formulations viz.
  • Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams.

Alpa Laboratories Ltd News Hub

News

Alpa Laboratories consolidated net profit rises 68.32% in the June 2024 quarter

Net profit of Alpa Laboratories rose 68.32% to Rs 5.10 crore in the quarter ended June 202...

Read more

2024-08-14 00:00:00

News

Alpa Laboratories standalone net profit rises 68.98% in the June 2024 quarter

Net profit of Alpa Laboratories rose 68.98% to Rs 5.12 crore in the quarter ended June 202...

Read more

2024-08-14 00:00:00

News

Alpa Laboratories to convene board meeting

Alpa Laboratories will hold a meeting of the Board of Directors of the Company on 13 Augus...

Read more

2024-08-05 00:00:00

News

Alpa Laboratories to conduct AGM

Alpa Laboratories announced that the Annual General Meeting (AGM) of the company will be h...

Read more

2024-09-19 00:00:00

News

Alpa Laboratories Ltd leads gainers in 'B' group

Vaswani Industries Ltd, FCS Software Solutions Ltd, Meera Industries Ltd and Zee Media Cor...

Read more

2024-09-27 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Alpa Laboratories Ltd

What is the current PE Ratio of Alpa Laboratories Ltd?

The Current PE Ratio of Alpa Laboratories Ltd is 11.44 as on 24 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 24 Nov 2024.

What was the PE Ratio of Alpa Laboratories Ltd last year?

The PE Ratio of Alpa Laboratories Ltd was 8.99 last year, now the PE ratio is 11.44, showing a year-on-year growth of 27.3%.

What does the PE Ratio of Alpa Laboratories Ltd indicate about its stock?

The PE Ratio of Alpa Laboratories Ltd is 11.44. This ratio indicates that investors are willing to pay 11.44 times the earnings per share for each share of Alpa Laboratories Ltd.

What is the PE Ratio Growth of Alpa Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Alpa Laboratories Ltd grew by 27.3% whereas, the EPS ratio grew by 51.2.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*